tirzepatide österreich Medicom | Presseinformation Eli Lilly Ges.m.b.H Tirzepatide 10mg - M&C Supply

No Generic Available: Eli Lilly holds patents on tirzepatide until around 2036-2040, meaning no true generic versions will be available for years

Foods to Limit or Avoid on Tirzepatide Certain foods are more likely to worsen side effects, especially early on or during dose increases

This dual GIP and GLP-1 receptor agonist, extensively studied in trials, demonstrates significant efficacy in body weight reduction and management of weight-related complications

It comes in two FDA-approved forms, both weekly injections: Mounjaro: type 2 diabetes (2.5 to 15 mg) Zepbound: obesity (2.5 to 15 mg) and moderate-to-severe obstructive sleep apnea in adults with obesity (approved December 2024) No oral tirzepatide exists as of April 2026

If you experience persistent or severe side effects, your prescriber may recommend slowing the dose escalation, dropping back to a lower dose temporarily, or trying a formulation with additives like glycine and B12 that can help reduce gastrointestinal symptoms

The Tirzepatide Injection Protocol from PlexusDx is a compounded GIP/GLP-1 dual agonist prescribed by licensed providers